Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2)

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 10, 2009, Pages 4949-4956

  Morales, Shawn A ^a   Mareninov, Sergey ^a   Coulam, Paige ^a   Wadehra, Madhuri ^a   Goodglick, Lee ^a   Braun, Jonathan ^a   Gordon, Lynn K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; EPITHELIAL MEMBRANE PROTEIN 2; F ACTIN; FOCAL ADHESION KINASE; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; ACTIN; ALPHA SMA PROTEIN, HUMAN; ALPHA-SMA PROTEIN, HUMAN; EMP2 PROTEIN, HUMAN; FOCAL ADHESION KINASE 1; PROTEIN TYROSINE KINASE; PTK2 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; WESTERN BLOTTING; CELL LINE; CONFOCAL MICROSCOPY; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACTINS; BLOTTING, WESTERN; CELL LINE; COLLAGEN TYPE I; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOCAL ADHESION KINASE 1; HUMANS; IMMUNOPRECIPITATION; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; PROTEIN BINDING; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 70349575016     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3315     Document Type: Article

References (44)

1. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A. 1992;89:5192-5196.
2. Rankin S, Rozengurt E. Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells: bell-shaped dose response and cross-talk with bombesin. J Biol Chem. 1994;269:704-710.
3. Seufferlein T, Rozengurt E. Lysophosphatidic acid stimulates tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130: signaling pathways and cross-talk with platelet-derived growth factor. J Biol Chem. 1994;269:9345-9351.
4. Seufferlein T, Rozengurt E. Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein. J Biol Chem. 1995;270:24334-24342.
5. Sieg DJ, Hauck CR, Ilic D, et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2000;2: 249-256.
6. Sinnett-Smith J, Zachary I, Valverde AM, Rozengurt E. Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation: role of protein kinase C, Ca2+ mobilization, and the actin cytoskeleton. J Biol Chem. 1993;268:14261-14268.
7. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol. 1995;15:954-963.
8. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol. 1999;71:435-478.
9. Schlaepfer DD, Hunter T. Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol. 1998;8:151-157.
10. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 2006;18:516-523.
11. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P. Integrinmediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 1994;372:786-791.
12. Nakamoto T, Sakai R, Honda H, et al. Requirements for localization of p130cas to focal adhesions. Mol Cell Biol. 1997;17:3884-3897.
13. Lunn JA, Jacamo R, Rozengurt E. Preferential phosphorylation of focal adhesion kinase tyrosine 861 is critical for mediating an anti-apoptotic response to hyperosmotic stress. J Biol Chem. 2007;282:10370-10379.
14. Wang CX, Wadehra M, Fisk BC, Goodglick L, Braun J. Epithelial membrane protein 2, a 4- transmembrane protein that suppresses B-cell lymphoma tumorigenicity. Blood. 2001;97:3890-3895.
15. Wadehra M, Sulur GG, Braun J, Gordon LK, Goodglick L. Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye. Exp Mol Pathol. 2003;74:106-112.
16. Wadehra M, Forbes A, Pushkarna N, et al. Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium. Dev Biol. 2005;287:336-345.
17. Wadehra M, Goodglick L, Braun J. The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins. Mol Biol Cell. 2004;15:2073-2083.
18. Wadehra M, Iyer R, Goodglick L, Braun J. The tetraspan protein epithelial membrane protein-2 interacts with beta1 integrins and regulates adhesion. J Biol Chem. 2002;277:41094-41100.
19. Wadehra M, Su H, Gordon LK, Goodglick L, Braun J. The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death. Clin Immunol. 2003;107:129-136.
20. Wadehra M, Dayal M, Mainigi M, et al. Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse. Dev Biol. 2006;292:430-441.
21. Boucheix C, Rubinstein E. Tetraspanins. Cell Mol Life Sci. 2001; 58:1189-1205.
22. Hemler ME. Specific tetraspanin functions. J Cell Biol. 2001;155: 1103-1107.
23. Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim YM, Lee H. Homophilic interactions of tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J Biol Chem. 2006;281:24279-24292.
24. Yauch RL, Hemler ME. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem J. 2000;351(pt 3):629-637.
25. Morales SA, Mareninov S, Wadehra M, et al. Epithelial membrane protein 2 (EMP2) controls collagen gel contraction in ARPE-19 cells by modulating FAK ACTIVATION. Invest Ophthalmol Vis Sci. 2009;50:462-469.
26. Morales SA, Mareninov S, Prasad P, Wadehra M, Braun J, Gordon LK. Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway. Exp Eye Res. 2007;85:790-798.
27. Jacamo RO, Rozengurt E. A truncated FAK lacking the FERM domain displays high catalytic activity but retains responsiveness to adhesion-mediated signals. Biochem Biophys Res Commun. 2005;334:1299-1304.
28. Harvey R, Hehir KM, Smith AE, Cheng SH. pp60c-src variants containing lesions that affect phosphorylation at tyrosines 416 and 527. Mol Cell Biol. 1989;9:3647-3656.
29. Lyman S, Gilmore A, Burridge K, Gidwitz S, White GC 2nd. Integrin- mediated activation of focal adhesion kinase is independent of focal adhesion formation or integrin activation: studies with activated and inhibitory beta3 cytoplasmic domain mutants. J Biol Chem. 1997;272:22538-22547.
30. Schaller MD, Otey CA, Hildebrand JD, Parsons JT. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol. 1995;130:1181-1187.
31. Parsons JT, Martin KH, Slack JK, Taylor JM, Weed SA. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene. 2000;19:5606-5613.
32. Cox BD, Natarajan M, Stettner MR, Gladson CL. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem. 2006;99:35-52.
33. Charteris DG, Sethi CS, Lewis GP, Fisher SK. Proliferative vitreoretinopathy- developments in adjunctive treatment and retinal pathology. Eye. 2002;16:369-374.
34. Kirchhof B. Strategies to influence PVR development. Graefes Arch Clin Exp Ophthalmol. 2004;242:699-703.
35. Lewis GP, Charteris DG, Sethi CS, Fisher SK. Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. Eye. 2002;16:375-387.
36. Baudouin C, Hofman P, Brignole F, Bayle J, Loubiere R, Gastaud P. Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy. Ophthalmologica. 1991;203:38-46.
37. Casaroli-Marano RP, Pagan R, Vilaro S. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1999;40:2062-2072.
38. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol. 1995;79:953-960.
39. Vinores SA, Campochiaro PA, McGehee R, Orman W, Hackett SF, Hjelmeland LM. Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci. 1990;31:2529-2545.
40. Nakamura K, Yano H, Schaefer E, Sabe H. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial- mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies. Oncogene. 2001;20:2626-2635.
41. Levy S, Shoham T. Protein-protein interactions in the tetraspanin web. Physiology (Bethesda). 2005;20:218-224.
42. Levy S, Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol. 2005;5:136-148.
43. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005;6:801-811.
44. Caplan MJ, Kamsteeg EJ, Duffield A. Tetraspan proteins: regulators of renal structure and function. Curr Opin Nephrol Hypertens. 2007;16:353-358.